Pelabresib-ruxolitinib combination reduces spleen volume, symptom score in myelofibrosis

Press/Media

Period	21 Dec 2022

Media coverage

Title	Pelabresib-ruxolitinib combination reduces spleen volume, symptom score in myelofibrosis
Media name/outlet	Healio
Country/Territory	United States
Date	21/12/22
URL	ct.moreover.com/?a=49559881268&p=1gw&v=1&x=QeR1lIB4KQPLPMI8qZ1Srw
Persons	John Mascarenhas